Currently out of the existing stock ratings of Thomas Stephan, 9 are a HOLD (37.5%), 15 are a BUY (62.5%).

Thomas Stephan

Work Performance Price Targets & Ratings Chart

Analyst Thomas Stephan, currently employed at STIFEL, carries an average stock price target met ratio of 67.71% that have a potential upside of 15.37% achieved within 66 days.

Thomas Stephan’s has documented 48 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GKOS, Glaukos Corp at 03-Sep-2024.

Wall Street Analyst Thomas Stephan

Analyst best performing recommendations are on STAA (STAAR SURGICAL COMPANY).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) at 12/8/2022. The price target of $60 was fulfilled within 1 day with a profit of $2.6 (4.15%) receiving and performance score of 41.53.

Average potential price target upside

GKOS Glaukos Corp SGHT Sight Sciences STAA STAAR Surgical Company RXST Rxsight

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$145

$3.25 (2.29%)

$110

9 days ago
(05-Nov-2024)

7/8 (87.5%)

$15.91 (12.32%)

41

Buy

$145

$3.25 (2.29%)

$130

2 months 11 days ago
(03-Sep-2024)

5/6 (83.33%)

$12 (9.02%)

108

Buy

$139

$-2.75 (-1.94%)

$131

2 months 17 days ago
(28-Aug-2024)

6/6 (100%)

$3.61 (2.67%)

106

Buy

$137

$-4.75 (-3.35%)

$113

3 months 13 days ago
(01-Aug-2024)

12/12 (100%)

$19.39 (16.49%)

110

Buy

$140

$-1.75 (-1.23%)

$105

3 months 13 days ago
(01-Aug-2024)

38/38 (100%)

$22.39 (19.04%)

129

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Thomas Stephan is most bullish on?

Potential upside of $16.99 has been obtained for RXST (RXSIGHT)

Which stock is Thomas Stephan is most reserved on?

Potential downside of $3.25 has been obtained for GKOS (GLAUKOS CORP)

What Year was the first public recommendation made by Thomas Stephan?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?